학술논문

Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial
Document Type
Article
Source
In The Lancet HIV January 2016 3(1):e13-e22
Subject
Primary Research
Articles
Language
ISSN
2352-3018